Alzheimer's disease

News

Biogen sees Spinraza slow down in Q3, bullish on Alzheimer's...

Biogen has given investors a pleasant surprise with better-than-expected profits in Q3, but has puzzled analysts with a rapid slowdown for its new rare disease drug Spinraza.

News

x-ray image of human head with brain and electric pulses

Non-drug approaches show promise against Alzheimer’s

The NeuroEM 1000 prevented and reversed memory loss in mice.

Views & Analysis

World Alzheimer's Day: latest research and a carer's perspec...

On World Alzheimer’s Day, pharmaphorum looks at statistics, current research and the impact of dementia on families.

News

Could light emitting wearable device treat dementia?

Device led to ‘significant clinical improvements' in Alzheimer's patients.

Views & Analysis

Alzheimer’s research needs international approach

New research initiatives aim to encourage pharma and academia to collaborate on dementia drug discovery, which is a high-risk field historically.

Biogen sees Spinraza slow down in Q3, bullish on Alzheimer's...

Non-drug approaches show promise against Alzheimer’s

World Alzheimer's Day: latest research and a carer's perspec...

Could light emitting wearable device treat dementia?

Alzheimer’s research needs international approach

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

Alzheimer's disease

Editor's Picks